|
Name |
(Z)-13-Octadecenal
|
Molecular Formula | C18H34O | |
IUPAC Name* |
(Z)-octadec-13-enal
|
|
SMILES |
CCCC/C=C\CCCCCCCCCCCC=O
|
|
InChI |
InChI=1S/C18H34O/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19/h5-6,18H,2-4,7-17H2,1H3/b6-5-
|
|
InChIKey |
QIRGIHPYVVKWTO-WAYWQWQTSA-N
|
|
Synonyms |
(Z)-13-Octadecenal; 58594-45-9; (Z)-octadec-13-enal; 13-Octadecenal, (13Z)-; 13-Octadecenal, (Z)-; 13Z-Octadecenal; FJA253248W; Z-13-Octadecanal; cis-13-Octadecenal; 13Z-Octadecanal; (13Z)-13-Octadecenal; UNII-FJA253248W; Z-13-Octadecenal; EINECS 261-349-4; (13Z)-octadec-13-enal; SCHEMBL811956; (13Z)-13-Octadecenal #; DTXSID2035774; OCTADECENAL, (Z)-13-; LMFA06000237; ZINC33840740; Q27278021
|
|
CAS | 58594-45-9 | |
PubChem CID | 5364497 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 266.5 | ALogp: | 7.2 |
HBD: | 0 | HBA: | 1 |
Rotatable Bonds: | 15 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 17.1 | Aromatic Rings: | 0 |
Heavy Atoms: | 19 | QED Weighted: | 0.195 |
Caco-2 Permeability: | -4.868 | MDCK Permeability: | 0.00002110 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0 |
Human Intestinal Absorption (HIA): | 0.018 | 20% Bioavailability (F20%): | 0.997 |
30% Bioavailability (F30%): | 0.999 |
Blood-Brain-Barrier Penetration (BBB): | 0.67 | Plasma Protein Binding (PPB): | 93.84% |
Volume Distribution (VD): | 4.084 | Fu: | 1.63% |
CYP1A2-inhibitor: | 0.218 | CYP1A2-substrate: | 0.207 |
CYP2C19-inhibitor: | 0.348 | CYP2C19-substrate: | 0.067 |
CYP2C9-inhibitor: | 0.165 | CYP2C9-substrate: | 0.948 |
CYP2D6-inhibitor: | 0.549 | CYP2D6-substrate: | 0.65 |
CYP3A4-inhibitor: | 0.402 | CYP3A4-substrate: | 0.059 |
Clearance (CL): | 3.585 | Half-life (T1/2): | 0.621 |
hERG Blockers: | 0.477 | Human Hepatotoxicity (H-HT): | 0.025 |
Drug-inuced Liver Injury (DILI): | 0.036 | AMES Toxicity: | 0.13 |
Rat Oral Acute Toxicity: | 0.018 | Maximum Recommended Daily Dose: | 0.045 |
Skin Sensitization: | 0.978 | Carcinogencity: | 0.186 |
Eye Corrosion: | 0.989 | Eye Irritation: | 0.987 |
Respiratory Toxicity: | 0.949 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001694 | 0.825 | D0O1PH | 0.635 | ||||
ENC001691 | 0.783 | D0O1TC | 0.475 | ||||
ENC001775 | 0.750 | D0Z5SM | 0.473 | ||||
ENC001681 | 0.746 | D05ATI | 0.457 | ||||
ENC001666 | 0.733 | D07ILQ | 0.456 | ||||
ENC001665 | 0.726 | D0OR6A | 0.417 | ||||
ENC001591 | 0.723 | D00AOJ | 0.402 | ||||
ENC001592 | 0.723 | D0UE9X | 0.400 | ||||
ENC001699 | 0.723 | D00FGR | 0.383 | ||||
ENC001555 | 0.723 | D0P1RL | 0.340 |